查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1936587

内视镜治疗设备市场机会、成长要素、产业趋势分析及2026年至2035年预测

Endotherapy Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球内视镜设备市场预计到 2025 年将达到 56 亿美元，到 2035 年将达到 117 亿美元，年复合成长率为 7.6%。

内视镜治疗器材市场-IMG1

推动市场成长的关键因素包括微创治疗方法的加速普及、治疗性内视镜技术的快速创新以及门诊和日间护理机构的兴起。内视镜治疗设备是专门设计的器械，用于辅助透过内视镜途径进行的治疗操作，无需大型手术切口即可进行体内治疗。这些设备使临床医生能够进行标靶治疗性介入，同时提高治疗精度并缩短患者恢復时间。医疗保健系统手术量的不断增长进一步推动了对先进内视镜治疗解决方案的需求。更高的可视性、设备柔软性、能量传输系统以及自动化技术的持续进步正在提高手术精度和患者安全性。这些进步正在扩大内视镜可治疗的疾病范围，并减少对传统手术的依赖。持续的技术升级也促进了设备的更新换代，因为医疗保健机构优先考虑能够带来更好临床效果和更高营运效率的现代化系统。

市场覆盖范围
开始年份 2025
预测年份 2026-2035
起始值 56亿美元
预测金额 117亿美元
复合年增长率 7.6%

内视镜治疗平台日趋精密，融合了高清成像、增强对比视觉化和先进光学技术。这些特性有助于提高检测能力和治疗精准度，从而增强临床信心并提高手术成功率。更清晰的视觉化效果在医疗机构推广应用方面持续发挥核心作用。

2025年，消化器官系统及配件市场份额将达到56.4%，这主要得益于持续高企的手术量以及治疗工具在常规内视镜诊疗中的广泛应用。胃肠道内视镜治疗在诊断和介入治疗中的广泛应用，使该细分市场保持主导。内视镜治疗方法的日益普及也持续支撑着该类别下专用配件和器械的持续需求。

预计到2025年，医院市场将占据54.6%的市场份额，并在2026年至2035年间达到62亿美元。医院需要处理各种各样的患者病例，并进行大量复杂的多学科手术，从而对先进的内视镜治疗技术产生了持续的需求。这些机构拥有完善的内视镜基础设施、先进的诊断影像系统和专业的临床知识，这增强了它们在市场推广方面的优势。

2025年，美国内视镜市场价值将达23亿美元。强大的报销体系和支持内视镜检查的医疗保健资金结构继续推动对现代内视镜设备的投资，从而在所有医疗保健机构中保持较高的使用率。

目录

第一章调查方法

  • 研究途径
  • 品质保证
    • GMI人工智慧政策与资料完整性承诺
      • 资讯来源完整性通讯协定
  • 调查可追溯性和可靠性评分
    • 勘测和步道组成部分
    • 评分组成部分
  • 数据收集
    • 主要资讯的部分列表
  • 资料探勘资讯来源
    • 付费资讯来源
      • 区域资讯来源
  • 基本估计值与计算
    • 两种方法的基准年计算均适用。
  • 预测模型
    • 量化市场影响分析
      • 生长参数对预测值的数学影响
  • 研究透明度附录
    • 资讯来源归属框架
    • 品质保证指标
    • 对信任的承诺

第二章执行摘要

第三章业界考察

  • 生态系分析
  • 产业影响因素
    • 司机
      • 胃肠道疾病盛行率不断上升
      • 对微创手术的需求日益增长
      • 频繁的内视镜检查
      • 内视镜设备的技术进步
    • 产业潜在风险与挑战
      • 先进内视镜治疗设备高成本
      • 手术相关併发症的风险
    • 市场机会
      • 一次性内视镜治疗设备的应用日益广泛
      • 机器人技术和人工智慧在内视镜治疗中的融合
  • 成长潜力分析
  • 监管环境
    • 北美洲
    • 欧洲
    • 亚太地区
  • 科技趋势
    • 当前技术趋势
    • 新兴技术
  • 救赎方案
  • 未来市场趋势
  • 价值链分析
  • 定价分析
  • Start-Ups场景
  • 消费者洞察
  • 波特五力分析
  • PESTEL 分析
  • 差距分析

第四章 竞争情势

  • 介绍
  • 企业矩阵分析
  • 公司市占率分析
    • 世界
    • 北美洲
    • 欧洲
    • 亚太地区
  • 竞争定位矩阵
  • 主要市场公司的竞争分析
  • 重大进展
    • 併购
    • 伙伴关係与合作
    • 新产品发布
    • 扩张计划

第五章 2022-2035年按产品分類的市场估算与预测

  • 消化系统医疗设备及配件
    • 切片检查钳
      • 一次性切片检查钳
      • 可重复使用的切片检查钳
      • 热切片检查钳
    • 针头
      • 超音波超音波引导下细针穿刺（FNA）针
      • 超音波超音波引导下细针穿刺切片（FNB）针
      • 其他注射针
    • 内视镜黏膜下剥离术（ESD）刀
      • 带针的刀
      • 绝缘刀尖
    • 息肉切除勒除器
    • 血夹
    • 夹钳
    • 止血钳
    • 硬化治疗针
    • 其他胃肠道医疗设备及配件
  • 内视镜逆行性胰造影（ERCP）器材及配件
    • 金属支架
    • 括约肌切开术
    • 导管导引线
    • 导管
      • 引导管
      • 扩张导管
      • 引流导管
      • 其他导管
    • 塑胶支架
    • 球囊扩张
    • 吸盘篮
    • 吸球
    • 其他ERCP器材和配件
  • 其他产品

第六章 按应用领域分類的市场估算与预测，2022-2035年

  • 胃肠内视镜检查
  • 腹腔镜
  • 关节镜
  • 泌尿系统内视镜治疗
  • 支气管镜检查
  • 其他用途

7. 依最终用途分類的市场估计与预测，2022-2035 年

  • 医院
  • 门诊手术中心
  • 其他用途

第八章 2022-2035年各地区市场估算与预测

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国

第九章：公司简介

  • B. BRAUN
  • Boston Scientific
  • CONMED
  • Cook Medical
  • Endo-Med
  • FUJIFILM
  • Johnson &Johnson
  • KARL STORZ
  • MI Tech
  • Medtronic
  • MICRO-TECH
  • OLYMPUS
  • Smith+Nephew
  • Stryker
  • TAEWOONG MEDICAL
简介目录
Product Code: 3782

The Global Endotherapy Devices Market was valued at USD 5.6 billion in 2025 and is estimated to grow at a CAGR of 7.6% to reach USD 11.7 billion by 2035.

Endotherapy Devices Market - IMG1

Market expansion is driven by the increasing shift toward minimally invasive treatment approaches, rapid innovation in therapeutic endoscopy technologies, and the growing number of outpatient and ambulatory care facilities. Endotherapy devices are specialized instruments designed to support therapeutic procedures performed through endoscopic access, enabling internal treatment without large surgical incisions. These devices allow clinicians to perform targeted therapeutic interventions with improved accuracy and reduced patient recovery time. Rising procedural volumes across healthcare systems are reinforcing demand for advanced endotherapy solutions. Continuous improvements in visualization quality, device flexibility, energy delivery systems, and automation are enhancing procedural precision and patient safety. These advancements are broadening the range of conditions that can be managed endoscopically, reducing reliance on conventional surgery. Ongoing technology upgrades are also contributing to replacement demand, as healthcare providers prioritize modern systems that deliver better clinical outcomes and operational efficiency.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$5.6 Billion
Forecast Value$11.7 Billion
CAGR7.6%

Endotherapy platforms are becoming increasingly sophisticated, integrating high-definition imaging, enhanced contrast visualization, and advanced optical technologies. These features support improved detection capabilities and more accurate therapeutic delivery, strengthening clinical confidence and improving procedural success rates. Enhanced visualization continues to play a central role in expanding adoption across healthcare facilities.

The gastrointestinal devices and accessories segment accounted for 56.4% share in 2025, supported by consistently high procedure volumes and widespread use of therapeutic tools in routine endoscopic care. The segment maintains its leadership position due to the broad application of gastrointestinal endotherapy across diagnostic and interventional procedures. Growing utilization of endoscopic treatment methods continues to support sustained demand for specialized accessories and devices within this category.

The hospitals segment generated 54.6% share in 2025 and is expected to reach USD 6.2 billion during 2026-2035. Hospitals manage a wide range of patient cases and perform a high volume of complex and multidisciplinary procedures, driving consistent demand for advanced endotherapy technologies. These facilities are equipped with comprehensive endoscopy infrastructure, advanced imaging systems, and specialized clinical expertise, reinforcing their dominance in market adoption.

U.S. Endotherapy Devices Market was valued at USD 2.3 billion in 2025. Strong reimbursement coverage for endoscopic procedures and supportive healthcare funding structures continue to encourage investment in modern endotherapy equipment, sustaining high utilization rates across care settings.

Key companies active in the Global Endotherapy Devices Market include Medtronic, OLYMPUS, Boston Scientific, KARL STORZ, FUJIFILM, Johnson & Johnson, Cook Medical, CONMED, Smith+Nephew, Stryker, B. BRAUN, Endo-Med, MICRO-TECH, M.I. Tech, and TAEWOONG MEDICAL. These companies maintain competitive positions through innovation, product breadth, and global distribution networks. To strengthen their presence, companies in the endotherapy devices sector focus heavily on continuous product innovation and technological differentiation. Strategic investments in advanced imaging, energy-based tools, and device miniaturization enhance clinical performance and usability. Manufacturers are expanding geographic reach through partnerships, acquisitions, and distribution agreements to access high-growth markets. Training programs and physician education initiatives are used to drive adoption and long-term customer loyalty.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product trends
    • 2.2.3 Application trends
    • 2.2.4 End use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of gastrointestinal disorders
      • 3.2.1.2 Growing demand for minimally invasive procedures
      • 3.2.1.3 High volume of endoscopic procedures
      • 3.2.1.4 Technological advancements in endoscopic devices
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of advanced endotherapy devices
      • 3.2.2.2 Risk of procedure-related complications
    • 3.2.3 Market opportunities
      • 3.2.3.1 Increasing adoption of single-use endotherapy devices
      • 3.2.3.2 Integration of robotics and AI in endotherapy
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Reimbursement scenario
  • 3.7 Future market trends
  • 3.8 Value chain analysis
  • 3.9 Pricing analysis
  • 3.10 Start-up scenarios
  • 3.11 Consumer insights
  • 3.12 Porter's analysis
  • 3.13 PESTEL analysis
  • 3.14 Gap analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Gastrointestinal devices & accessories
    • 5.2.1 Biopsy forceps
      • 5.2.1.1 Single-use biopsy forceps
      • 5.2.1.2 Reusable biopsy forceps
      • 5.2.1.3 Hot biopsy forceps
    • 5.2.2 Injection needles
      • 5.2.2.1 EUS-guided FNA (fine needle aspiration) needles
      • 5.2.2.2 EUS-guided FNB (fine needle biopsy) needles
      • 5.2.2.3 Other injection needles
    • 5.2.3 Endoscopic submucosal dissection (ESD) knives
      • 5.2.3.1 Needle-tipped knives
      • 5.2.3.2 Insulation-tipped knives
    • 5.2.4 Polypectomy snares
    • 5.2.5 Hemoclips
    • 5.2.6 Graspers
    • 5.2.7 Hemostasis forceps
    • 5.2.8 Sclerotherapy needles
    • 5.2.9 Other gastrointestinal devices & accessories
  • 5.3 Endoscopic retrograde cholangiopancreatography (ERCP) devices & accessories
    • 5.3.1 Metal stents
    • 5.3.2 Sphincterotome
    • 5.3.3 Guide wire
    • 5.3.4 Catheter
      • 5.3.4.1 Guiding catheter
      • 5.3.4.2 Dilation catheter
      • 5.3.4.3 Drainage catheter
      • 5.3.4.4 Other catheters
    • 5.3.5 Plastic stents
    • 5.3.6 Balloon dilation
    • 5.3.7 Extraction basket
    • 5.3.8 Extraction balloon
    • 5.3.9 Other ERCP devices & accessories
  • 5.4 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Gastrointestinal endoscopy
  • 6.3 Laparoscopy
  • 6.4 Arthroscopy
  • 6.5 Urology endotherapy
  • 6.6 Bronchoscopy
  • 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 B. BRAUN
  • 9.2 Boston Scientific
  • 9.3 CONMED
  • 9.4 Cook Medical
  • 9.5 Endo-Med
  • 9.6 FUJIFILM
  • 9.7 Johnson & Johnson
  • 9.8 KARL STORZ
  • 9.9 M.I. Tech
  • 9.10 Medtronic
  • 9.11 MICRO-TECH
  • 9.12 OLYMPUS
  • 9.13 Smith+Nephew
  • 9.14 Stryker
  • 9.15 TAEWOONG MEDICAL